Submitted by Anonymous (not verified) on 1 December 2025 - 14:45
Human medicines European public assessment report (EPAR): Rivastigmine Sandoz, rivastigmine, Date of authorisation: 10/12/2009, Revision: 18, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Rivastigmine Sandoz, rivastigmine, Date of authorisation: 10/12/2009, Revision: 18, Status: Authorised